-
1
المؤلفون: Alexandros Stratigos, Dimitrios Rigopoulos, Stamatios Gregoriou, Anna Campanati, George Kontochristoulos, Annamaria Offidani
المصدر: Expert Opinion on Investigational Drugs. 30:479-482
مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Administration, Topical, Cholinergic Antagonists, 03 medical and health sciences, 0302 clinical medicine, Drug Development, medicine, Humans, Hyperhidrosis, Pharmacology (medical), Oxybutynin, Adverse effect, Glycopyrrolate, Focal hyperhidrosis, Pharmacology, business.industry, Incidence (epidemiology), Drugs, Investigational, General Medicine, medicine.disease, Dermatology, 030104 developmental biology, 030220 oncology & carcinogenesis, medicine.symptom, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16950dae2cb54d83b93fb20aa29dea40Test
https://doi.org/10.1080/13543784.2021.1900114Test -
2
المؤلفون: Jeffrey R. Livezey, Thomas Oliver, Daniel J. Selig, Elaine D. Por, Jesse P. DeLuca, Adrian T. Kress, Rosenie Thelus Jean, Aaron J. Brown
المصدر: Pharmacoepidemiology and Drug Safety. 29:1605-1615
مصطلحات موضوعية: Adult, medicine.medical_specialty, endocrine system diseases, Epidemiology, Military Health Services, Population, Muscarinic Antagonists, 030226 pharmacology & pharmacy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Fesoterodine, Darifenacin, Humans, Pharmacology (medical), 030212 general & internal medicine, Risk factor, Oxybutynin, education, Aged, Retrospective Studies, Aged, 80 and over, education.field_of_study, Solifenacin, Antimuscarinic Agent, Urinary Bladder, Overactive, business.industry, Middle Aged, Diabetes Mellitus, Type 2, Female, Tolterodine, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::036bcf70642bdadfd60f2bb0c5bd3df2Test
https://doi.org/10.1002/pds.5090Test -
3
المصدر: Pharmacoepidemiol Drug Saf
مصطلحات موضوعية: medicine.medical_specialty, Epidemiology, Urinary Bladder, Muscarinic Antagonists, Medicare, 030226 pharmacology & pharmacy, Article, 03 medical and health sciences, 0302 clinical medicine, Alzheimer Disease, Internal medicine, medicine, Fesoterodine, Darifenacin, Humans, Pharmacology (medical), 030212 general & internal medicine, Oxybutynin, Aged, Retrospective Studies, Solifenacin, business.industry, Incidence (epidemiology), food and beverages, Retrospective cohort study, Odds ratio, United States, Pharmaceutical Preparations, Tolterodine, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dedd87cdee746c1c10a111e536931638Test
https://doi.org/10.1002/pds.5098Test -
4
المؤلفون: Aki Shiozawa, J.R. Earla, Carol R. Schermer, Rajender R. Aparasu, Daniel B. Ng, S.D. Sura
المصدر: Advances in Therapy
مصطلحات موضوعية: Male, 030213 general clinical medicine, medicine.medical_specialty, Pyrrolidines, medicine.drug_class, Urology, Antimuscarinic, Muscarinic Antagonists, Medicare, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Anticholinergic, Humans, Pharmacology (medical), Oxybutynin, Aged, Benzofurans, Proportional Hazards Models, Retrospective Studies, Original Research, Aged, 80 and over, Solifenacin, Antimuscarinic Agent, Urinary Bladder, Overactive, Nursing home, business.industry, Overactive bladder, Retrospective cohort study, General Medicine, medicine.disease, United States, Nursing Homes, Discontinuation, Withholding Treatment, Adherence, 030220 oncology & carcinogenesis, Mandelic Acids, Urological Agents, Female, Tolterodine, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02f04538eefb620e454bbf3ba577f9adTest
https://doi.org/10.1007/s12325-020-01412-zTest -
5
المصدر: Expert Opinion on Drug Safety. 18:915-923
مصطلحات موضوعية: Male, Tamsulosin, medicine.medical_specialty, Urinary system, Prostatic Hyperplasia, Muscarinic Antagonists, 030204 cardiovascular system & hematology, 03 medical and health sciences, 5-alpha Reductase Inhibitors, Cognition, 0302 clinical medicine, Lower Urinary Tract Symptoms, Lower urinary tract symptoms, Internal medicine, medicine, Animals, Humans, Dementia, Pharmacology (medical), Oxybutynin, Adverse effect, Dose-Response Relationship, Drug, Urinary Bladder, Overactive, business.industry, General Medicine, medicine.disease, Discontinuation, Affect, Mood, 030220 oncology & carcinogenesis, Adrenergic alpha-1 Receptor Antagonists, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eb679087faf19e2edb608433ff8030fTest
https://doi.org/10.1080/14740338.2019.1652269Test -
6
المؤلفون: Pablo Anaya, Katherine Dea, Giovanny Montoya, Daniel Bin Ng, Robert Espinosa, Hélène Parise
المصدر: PharmacoEconomics Open
مصطلحات موضوعية: Pharmacology, medicine.medical_specialty, business.industry, Cost effectiveness, medicine.drug_class, Health Policy, medicine.disease, Comorbidity, Discontinuation, Overactive bladder, Internal medicine, Anticholinergic, Medicine, Pharmacology (medical), Original Research Article, Tolterodine, business, Mirabegron, Oxybutynin, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::feb1c7da41c288932a0ea177ddac36cdTest
https://doi.org/10.1007/s41669-019-0149-9Test -
7
المؤلفون: Katsumi Kadekawa, Shizuo Yamada, Yoshihiko Ito, Saori Nishijima, Kimio Sugaya
المصدر: Pharmacology & Therapeutics. 189:130-148
مصطلحات موضوعية: medicine.medical_specialty, 030232 urology & nephrology, Urology, Muscarinic Antagonists, urologic and male genital diseases, 03 medical and health sciences, 0302 clinical medicine, Fesoterodine, medicine, Darifenacin, Animals, Humans, Pharmacology (medical), Oxybutynin, Pharmacology, Solifenacin, Antimuscarinic Agent, Urinary Bladder, Overactive, business.industry, Brain, medicine.disease, female genital diseases and pregnancy complications, Overactive bladder, 030220 oncology & carcinogenesis, Propiverine, Tolterodine, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76ff57c7ef5b5a493a6e2cb228497882Test
https://doi.org/10.1016/j.pharmthera.2018.04.010Test -
8
المصدر: Therapeutics and Clinical Risk Management. 14:1657-1660
مصطلحات موضوعية: Liver injury, medicine.medical_specialty, Weakness, Chemical Health and Safety, business.industry, General Medicine, Emergency department, medicine.disease, Naranjo Adverse Drug Reaction Probability Scale, 03 medical and health sciences, 0302 clinical medicine, Overactive bladder, Internal medicine, medicine, 030211 gastroenterology & hepatology, Pharmacology (medical), 030212 general & internal medicine, General Pharmacology, Toxicology and Pharmaceutics, medicine.symptom, business, Oxybutynin, Safety Research, Stroke, Adverse drug reaction, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::cd6fca28c212c6aa9cb1ad94865e722aTest
https://doi.org/10.2147/tcrm.s169868Test -
9
المؤلفون: Peter Rubenwolf, Ahmed Abbas Suleiman, Uwe Fuhr, Petra Krause, Raimund Stein, Uwe Albrecht, Melanie Kretschmar, Max Taubert
المصدر: Journal of clinical pharmacologyReferences. 61(7)
مصطلحات موضوعية: medicine.medical_specialty, Metabolic Clearance Rate, Population, Urology, Administration, Oral, 030226 pharmacology & pharmacy, Models, Biological, Cholinergic Antagonists, 03 medical and health sciences, Route of administration, 0302 clinical medicine, Pharmacokinetics, Oral administration, medicine, Humans, Pharmacology (medical), Oxybutynin, education, Pharmacology, education.field_of_study, Dose-Response Relationship, Drug, business.industry, Healthy Volunteers, NONMEM, Bioavailability, Administration, Intravesical, Tolerability, 030220 oncology & carcinogenesis, Area Under Curve, Mandelic Acids, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e158a44f7e8aeae609afd088725a77c3Test
https://pubmed.ncbi.nlm.nih.gov/33368382Test -
10
المؤلفون: Blayne Welk, Eric McArthur
المصدر: Pharmacoepidemiology and drug safetyREFERENCES. 29(12)
مصطلحات موضوعية: Ontario, medicine.medical_specialty, Solifenacin, Epidemiology, medicine.drug_class, business.industry, Depression, Urinary Bladder, Overactive, Hazard ratio, medicine.disease, Cholinergic Antagonists, Cohort Studies, Overactive bladder, Internal medicine, medicine, Anticholinergic, Humans, Pharmacology (medical), Tolterodine, business, Mirabegron, Oxybutynin, Depression (differential diagnoses), medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::536ae14268b81e4968cdfa527c53fbddTest
https://pubmed.ncbi.nlm.nih.gov/33015899Test